Journal Report

Expert Review of Anticancer Therapy

Download PDF
Journal Information
Journal Title
Expert Review of Anticancer Therapy
Publisher
Taylor and Francis Ltd.
ISSN
1473-7140
E-ISSN
1744-8328
Database
SCOPUS
Domain
Health Sciences, Life Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
From collision to conversion, the molecular renaissance of uterine carcinosarcoma in the era of antibody-drug conjugates: a scoping review
Marco D’indinosante, Maria Consiglia Giuliano, Giuseppe Parisi et al.
2026-11-13
DOI: 10.1080/14737140.2026.2762698
Evaluating vorasidenib in the treatment of IDH1-mutant or IDH2-mutant low-grade gliomas
Xin Wang, Thiago Muniz, Warren Mason
2026-11-11
DOI: 10.1080/14737140.2026.2763249
Biological state–guided oncology: a framework for dynamic precision cancer care through oncological state transitions
Takehiro Okabayashi, Ryo Inada, Motoyasu Tabuchi et al.
2026-11-9 Pages 1-13
DOI: 10.1080/14737140.2026.2760189
Trastuzumab deruxtecan in HER2-expressing urothelial carcinoma: current evidence, biomarker challenges, and future therapeutic strategies
Giandomenico Roviello, Kristian Shtembari, Ismaela Anna Vascotto et al.
2026-11-5 Pages 1-10
DOI: 10.1080/14737140.2026.2760188
TROP2-directed antibody-drug conjugates (ADCs) challenge of predicting clinical outcome
Laura Stanbery, Daniel Craig, Lauren Rager et al.
2026-11-4 Pages 1-13
DOI: 10.1080/14737140.2026.2756200
Survivorship in gynecological cancers: addressing psychosocial and physical challenges
Hadley W. Reid, Brittany A. Davidson
2026-11-3 Pages 1-13
DOI: 10.1080/14737140.2026.2758536
Uveal melanoma: innovations in therapy, prognosis, and imaging
Nikhith Rao, Shrihari Nagarajan, Lauren A. Dalvin
2026-10-29 Pages 1-19
DOI: 10.1080/14737140.2026.2755251
Myelodysplastic syndromes/neoplasms presenting with isolated thrombocytopenia: a poorly understood pathophysiology, difficult to diagnose, and challenging to treat entity
Shehab F. Mohamed, Mohammed Abdulgayoom, Abdulrahman F. Al-Mashdali et al.
2026-10-29 Pages 1-19
DOI: 10.1080/14737140.2026.2746616
Apalutamide in prostate cancer: clinical evidence, disease modification hypothesis, and emerging treatment de‑intensification strategies
Martina Catalano, Giandomenico Roviello
2026-10-15 Pages 1-8
DOI: 10.1080/14737140.2026.2749345
Targeting <i>KIT</i> and <i>PDGFRA</i> mutations in advanced GIST: current and future clinical implications
Alice Costa, Annalisa Astolfi, Livia Gozzellino et al.
2026-10-11 Pages 1-11
DOI: 10.1080/14737140.2026.2746618
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 14, 2026 21:12